8 Documents disponibles écrits par cet auteur
Harm reduction is based on the idea that people have the right to be safe and supported even if they are not ready or willing to abstain from illicit drug use. A harm reduction approach involves giving people who use drugs choices that can help [...]
FRANÇAIS : Ce rapport explore l'intersection entre la politique en matière de drogues et les tendances de l'épidémie au VIH, en ciblant les pays où l'usage de matériel d'injection contaminé constitue le premier mode de contamination. Dans sa[...]
ENGLISH : 2008 could be a landmark year for progress on a vexing global public-health problem, the use of illicit drugs. Beginning in March, member states of the UN have been asked to engage in a year of reflection to gauge progress in the dec[...]![Seeing through the public health smoke-screen in drug policy [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_78956.webp?v=1773909253)
J. CSETE ; D. WOLFE | 2017
Dans International Journal of Drug Policy (Vol.43, May 2017) Article : PériodiqueIn deliberations on drug policy in United Nations fora, a consensus has emerged that drug use and drug dependence should be treated primarily as public health concerns rather than as crimes. But what some member states mean by "public health app[...]
L. DEGENHARDT ; D. WOLFE ; W. HALL ; M. HICKMAN ; J. CHANG ; J. BRUNEAU ; M. FARRELL ; P. GRIFFITHS | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : PériodiqueThe 1961 UN Single Convention on Narcotic Drugs proposed to end all non-medical use of cannabis, coca, opium poppy, and their derivatives. In the nearly 60 years since then, global drug use and harm have increased despite better scientific under[...]
D. WOLFE ; M. P. CARRIERI ; SHEPARD D. | 2010
Dans Lancet (The) (Vol.376, n°9738, Jul 31, 2010) Article : PériodiqueWe review evidence for effectiveness, cost-effectiveness, and coverage of antiretroviral therapy (ART) for injecting drug users (IDUs) infected with HIV, with particular attention to low-income and middle-income countries. In these countries, ne[...]
L. DEGENHARDT ; B. M. MATHERS ; A. L. WIRTZ ; D. WOLFE ; A. KAMARULZAMAN ; M. P. CARRIERI ; S. A. STRATHDEE ; K. MALINOWSKA-SEMPRUCH ; M. KAZATCHKINE ; C. BEYRER | 2014
Dans International Journal of Drug Policy (Vol.25, n°1, January 2014) Article : PériodiqueOBJECTIVE: In 2010 the international HIV/AIDS community called on countries to take action to prevent HIV transmission among people who inject drugs (PWID). To set a baseline we proposed an "accountability matrix", focusing upon six countries ac[...]
Historique
![Methadone in primary care in France: Using evidence for action against hepatitis C [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_82229.webp?v=1773868171)